# Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD

> **NCT00766649** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 11 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00766649
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766649, "Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00766649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*